U.S. Court of Appeals for the Federal Circuit, 2005

Novo Nordisk Pharmaceuticals v. Bio-Technology General [Correction]

Novo Nordisk Pharmaceuticals v. Bio-Technology General [Correction]
U.S. Court of Appeals for the Federal Circuit · Decided October 5, 2005

Novo Nordisk Pharmaceuticals v. Bio-Technology General [Correction]

Opinion

United States Court of Appeals for the Federal Circuit CORRECTED: October 5, 2005 at 1:00 PM 04-1581

NOVO NORDISK PHARMACEUTICALS, INC., and NOVO NORDISK A/S, Plaintiffs-Appellants, v.

BIO-TECHNOLOGY GENERAL CORP. and TEVA PHARMACEUTICALS USA, INC., Defendants-Appellees.

Steven E. Lipman, Darby & Darby, P.C., of New York, New York, argued for plaintiffs-appellants. Of counsel were James Edward Hanft, Paul M. Zagar, Jay P. Lessler, Kevin L. Reiner, Robert Schaffer and Joseph R. Robinson.

John W. Bateman, Kenyon & Kenyon, of Washington, DC, argued for defendants-appellees. On the brief was Richard L. DeLucia, of New York, New York.

Of counsel were Steven J. Lee, and Thomas J. Meloro, of New York, New York, and Kenneth R. Corsello, of Washington, DC.

Appealed from: United States District Court for the District of Delaware .

Chief Judge Sue L. Robinson

Case-law data current through December 31, 2025. Source: CourtListener bulk data.